Home > Insider Trading > Filing (0001209191-17-021567)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1640522	G. Steven Brodie	12701 Commonwealth Drive Suite 9 Fort Myers FL 33913	President, Pharma Services	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-03-13	16,550	$8.00	49,403	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$3.76	2014-04-16	2018-04-16	10,000	10,000	Direct
Common Stock	Stock Option (Right to Buy)	$3.45	2015-03-05	2019-03-05	20,000	20,000	Direct
Common Stock	Stock Option (Right to Buy)	$4.78	2016-05-04	2020-05-04	120,000	120,000	Direct
Common Stock	Stock Option (Right to Buy)	$7.15	2017-04-20	2021-04-20	100,000	100,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-04-16	10,000	10,000	Direct
2019-03-05	20,000	20,000	Direct
2020-05-04	120,000	120,000	Direct
2021-04-20	100,000	100,000	Direct

Footnotes

On April 16, 2013 Dr. Brodie was granted 10,000 stock options. These options will vest ratably over the next three anniversary dates of the grant dates.
On March 5, 2014 Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
On May 4, 2015 Dr, Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
On April 20, 2016, Mr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.